Phase 2 Data Highlight Roflumilast Cream in Infant AD Dermatology Times Source link
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities The Globe and Mail Source link
First cream created to treat hand eczema approved to be rolled out on the NHS Daily Mail Source link
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) BioSpace Source link